Vitamin D May Lower Autoimmune Disease Risk: What the VITAL Trial Found

19 Jul 2026·HealthyMag Editorial Team

Vitamin D capsules with salmon, eggs, mushrooms and a sunny window

Reviewed by the HealthyMag Editorial Team. Last updated: July 2026.

Quick Answer: In the large VITAL randomized trial (Hahn J, et al., BMJ 2022), older adults who took 2,000 IU of vitamin D3 daily for about five years had roughly a 22% lower rate of newly diagnosed autoimmune diseases than those on placebo (hazard ratio 0.78). That is a genuinely notable result, because it comes from a randomized controlled trial rather than the weaker observational studies that dominate supplement research. But the absolute benefit was modest, it is a single trial, and it does not mean everyone should megadose. For most adults, 2,000 IU per day is a reasonable and safe amount, though supplements are not a substitute for medical care and this is not medical advice.

What the VITAL trial actually found

VITAL (the VITamin D and OmegA-3 TriaL) enrolled 25,871 US adults — men aged 50 and older and women aged 55 and older — and randomly assigned them to take vitamin D3, marine omega-3 fatty acids, both, or placebo. The autoimmune-disease analysis, published by Hahn J and colleagues in The BMJ in 2022 (BMJ 2022;376:e066452), followed participants for a median of about 5.3 years and tracked how many developed a new autoimmune condition such as rheumatoid arthritis, psoriasis, autoimmune thyroid disease, or polymyalgia rheumatica.

The headline result: people taking 2,000 IU of vitamin D3 per day had a hazard ratio of 0.78 (95% confidence interval 0.61 to 0.99) for developing an autoimmune disease — about a 22% lower rate than placebo. The omega-3 arm (1,000 mg per day) showed a smaller, less definitive signal, with a hazard ratio of 0.85 (95% CI 0.67 to 1.08), a roughly 15% reduction that did not reach statistical significance on its own. In other words, the vitamin D finding was the clearer one, and the omega-3 finding was suggestive but not conclusive.

Why a randomized trial matters more than observational data

Most of what you read about vitamin D comes from observational studies — researchers measure people’s vitamin D levels, then watch who gets sick. The problem is that low vitamin D often travels with other things: less time outdoors, more illness, obesity, older age, poorer overall health. When those people later develop disease, it is genuinely hard to know whether low vitamin D caused it or was just a marker of being less healthy to begin with. This is called confounding, and it has repeatedly made supplements look more powerful than they turn out to be in rigorous testing.

A randomized controlled trial like VITAL sidesteps that problem. By randomly assigning who gets vitamin D and who gets a placebo, the two groups end up similar in every other respect — age, health, lifestyle, sun exposure — so any difference in outcomes can be attributed to the supplement itself. That is why a positive RCT signal for a supplement is relatively rare and worth paying attention to. Many supplements that looked promising in observational data (vitamin E, beta-carotene, high-dose vitamin C) failed when finally tested in trials. VITAL is notable precisely because vitamin D held up.

What “autoimmune disease” means

An autoimmune disease occurs when the immune system, which normally attacks bacteria and viruses, mistakenly targets the body’s own tissues. There are more than 80 recognized autoimmune conditions, including rheumatoid arthritis (joints), Hashimoto’s and Graves’ disease (thyroid), psoriasis (skin), type 1 diabetes (pancreas), and lupus (multiple organs). Collectively they are common, often lifelong, and can be disabling. Because they are frequently diagnosed in mid-to-later life, VITAL’s older population was a reasonable place to look for a prevention effect.

Why vitamin D might influence the immune system

The biology behind the finding is plausible. Almost every immune cell carries vitamin D receptors, and vitamin D helps regulate the immune response — nudging it away from the kind of over-reactive, self-directed inflammation that underlies autoimmune disease. In laboratory and animal studies, adequate vitamin D appears to support regulatory T cells and dampen inflammatory signaling. That mechanistic story does not prove anything on its own — plenty of biologically plausible ideas fail in humans — but it makes VITAL’s result easier to believe rather than dismiss as a fluke.

The honest caveats

This is a strong result, but it deserves careful framing. First, while a 22% relative reduction sounds large, the absolute reduction was modest: autoimmune diseases were uncommon in both groups, so the actual number of cases prevented over five years was small. Relative percentages always sound more dramatic than the real-world numbers behind them.

Second, VITAL is one trial. Even excellent single studies need replication before findings are considered settled, and the confidence interval for vitamin D (0.61 to 0.99) reaches close to 1.0 — meaning the benefit, while statistically significant, could be smaller than the headline suggests. Follow-up analyses of VITAL presented in later years have continued to explore whether the effect holds over time.

Third, VITAL studied older adults; it does not tell us much about younger people or those already vitamin D deficient, who might respond differently. And it does not mean more is better. Taking very high doses in hopes of a bigger effect is not supported by this trial and can cause harm.

The practical takeaway

For most adults, 2,000 IU (50 micrograms) of vitamin D3 per day — exactly the dose VITAL used — is a reasonable, well-tolerated amount that sits comfortably within established safety limits. It is not a treatment for autoimmune disease and it is not a guarantee against one, but the evidence that it is broadly safe at this dose is solid, and VITAL provides real (if modest) reason to think it may offer some protective benefit as you age. The sensible move is to discuss it with your doctor, especially if you have kidney disease, take other medications, or already supplement, so any decision fits your individual health picture.

🛒 Where to buy: If your doctor agrees vitamin D makes sense for you, you can compare vitamin D3 supplements on Amazon here. (As an Amazon Associate we earn from qualifying purchases.)

Frequently Asked Questions

Does vitamin D prevent autoimmune disease?

The VITAL trial (Hahn J, et al., BMJ 2022) found that 2,000 IU of vitamin D3 daily reduced the rate of new autoimmune diseases by about 22% over roughly five years in older adults. That is meaningful evidence from a randomized trial, but “prevent” is too strong a word — the absolute reduction was modest, it is one study, and many people still developed autoimmune disease despite taking it. It may lower risk somewhat; it does not eliminate it.

How much vitamin D should I take?

VITAL used 2,000 IU (50 micrograms) of vitamin D3 per day, which is a common, reasonable supplement dose. The NIH Office of Dietary Supplements lists the recommended dietary allowance for most adults at 600 to 800 IU per day from all sources, so 2,000 IU is a moderate supplemental amount. Your ideal dose depends on your blood levels, diet, and sun exposure, so it is worth asking your doctor.

Is 2,000 IU of vitamin D safe?

For most adults, yes. The NIH Office of Dietary Supplements sets the tolerable upper intake level for adults at 4,000 IU per day, so 2,000 IU sits well within that safety margin, and it was well tolerated in the VITAL trial. Very high doses over long periods can cause harm (including high blood calcium), so more is not better. People with kidney disease or certain conditions should check with a doctor first.

Does this apply to everyone?

Not necessarily. VITAL studied men aged 50 and older and women aged 55 and older, so its findings apply most directly to older adults. It tells us less about younger people, children, or those who are already significantly vitamin D deficient, who may respond differently. The results are a reasonable guide for many middle-aged and older adults but should not be assumed to apply universally.

Should I get my vitamin D levels tested?

Testing can be helpful, especially if you have limited sun exposure, darker skin, a malabsorption condition, or a history of low levels — it lets you and your doctor tailor a dose rather than guess. That said, VITAL gave a fixed 2,000 IU dose without screening participants first, and it still saw a benefit. Whether to test is a reasonable conversation to have with your healthcare provider.

What about the omega-3 part of the trial?

VITAL also tested 1,000 mg per day of marine omega-3 fatty acids. Omega-3 showed a smaller, suggestive reduction in autoimmune disease (hazard ratio 0.85, about 15%) that did not reach statistical significance on its own, so the evidence there is weaker and less certain than for vitamin D. Interestingly, the combination of both supplements appeared to produce the largest effect, but that comparison needs confirmation in further research.

Sources

Hahn J, Cook NR, Alexander EK, Friedman S, Walter J, Bubes V, Kotler G, Lee I-M, Manson JE, Costenbader KH. “Vitamin D and marine omega-3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial.” The BMJ, 2022;376:e066452. doi:10.1136/bmj-2021-066452. PubMed
National Institutes of Health, Office of Dietary Supplements. “Vitamin D — Fact Sheet for Health Professionals.” ods.od.nih.gov

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making any health decisions. Content reviewed by the HealthyMag Editorial Team.